Author:
Huang Chi-Cheng,Tsai Yi-Fang,Liu Chun-Yu,Lien Pei-Ju,Lin Yen-Shu,Chao Ta-Chung,Feng Chin-Jung,Chen Yen-Jen,Lai Jiun-I,Phan Nam Nhut,Hsu Chih-Yi,Chiu Jen-Hwey,Tseng Ling-Ming
Funder
YongLin Health Care Foundation
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Most common cancer diagnosis globally: breast surpasses lung - medscape Dec 17, 2020. Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, Delaloge S, Li W, Tung N, Armstrong A, Wu W, Goessl C, Runswick S, Conte P. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med. 2017;377:523-33. URL: https://www.medscape.com/viewarticle/942808. Accessed Mar 17, 2021.
2. Health Promotion Administration, Ministry of Health and Welfare, Taiwan. Cancer registry annual report, 2017, Taiwan. Taipei: Health Promotion Administration, Ministry of Health and Welfare, Taiwan, 2019.
3. Department of Statistics, Ministry of Health and Welfare, Taiwan. Cause of death statistics, 2019, Taiwan. https://www.mohw.gov.tw/cp-16-54482-1.html (2019, Accessed 24 Sept 2020).
4. Kuo CN, Liao YM, Kuo LN, Tsai HJ, Chang WC, Yen Y. Cancers in Taiwan: practical insight from epidemiology, treatments, biomarkers, and cost. J Formos Med Assoc. 2020;119(12):1731–41.
5. US Preventive Services Task Force, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Doubeni CA, Epling JW Jr, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Risk assessment, genetic counseling, and genetic testing for BRCA-related Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019; 322(7):652-65.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献